Skip to main content

Day: March 18, 2024

Peapack Private Investment Banking Advises Super Stud Building Products, Inc. and Affiliates on the Sale to EB Metals, Inc.

Peapack-Gladstone Financial CorporationEric H. Waser, Executive Vice President, Head of Investment BankingBEDMINSTER, NJ, March 18, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market:  PGC), the holding company for Peapack-Gladstone Bank and its Investment Banking division, Peapack Private Investment Banking, is pleased to announce its participation in the transition of Super Stud Building Products Inc. and affiliates, owned and operated by Ray Frobosilo, Sr., to EB Metals Inc. and affiliates.  The financial terms of the sale were not disclosed. Ray Frobosilo, Sr. and his family are recognized as industry pioneers in manufacturing and diverse offerings of cold-formed steel framing components, hollow metal doors and frames, and accessories for the use in the construction...

Continue reading

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

Register for Webinar to be held on March 20, 2024 at 3:00 pm EDT PITTSBURGH, March 18, 2024 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell” or the “Company”), today announced it will host an Investor Webinar titled “Unveiling the Secretome: On the Eve of Product Launch” on March 20, 2024 at 3:00 PM ET to discuss Carmell Secretome™, the biggest technological revolution in regenerative skin and haircare to the fast-growing ~$500 billion aesthetics industry. To register, click here. The event will feature Rajiv Shukla, Chairman & CEO of Carmell, joined by key opinion leaders (KOLs), Dr Gilles Spenlehauer, PhD (former Worldwide head of research for L’Oreal, the world’s #1 cosmetics company) and Leonard Miller MD, FACS, FRCS (Clinical Instructor at...

Continue reading

61065483

Iveco Group initiates transition to new Chief Human Resources Officer Turin, 18th March 2024. Iveco Group N.V. (EXM: IVG) today announces that Francesco Tutino, having contributed importantly to the Company’s successful spin-off and first two years of independence in his role as Chief Human Resources & IT Officer, will be taking up a new position in another industry sector within the end of the second quarter of this year. Until then he will continue to serve in his current responsibilities and to ensure continuity. The search process to identify Mr. Tutino’s successor is already under way, with a view to making an appointment by the end of this transitional period. Gerrit Marx, CEO, Iveco Group, said: “I want to thank Francesco for his passion, tenacity and leadership. He has been a key member of the Senior Leadership Team...

Continue reading

EDF responds to the request of the French government to study the creation of an irradiation department to support the CEA

EDF responds to the request of the French government to study the creation of an irradiation department to support the CEA Paris, 18 March 2024 EDF has been seized by the French government to provide an irradiation service at Civaux nuclear power plant, in support of the CEA (Commissariat à l’énergie atomique – Atomic Energy Comission). An irradiation service involves inserting radioactive material into the reactor core. The purpose of EDF’s nuclear reactors, including Civaux, is to produce low-carbon, pilotable electricity to support energy transition in France. This complementary activity will be added to the main mission of electricity generation. This request from the French government has no impact on Civaux’s operations or its purpose. In addition, the two Civaux reactors remain subject to the civil nuclear installations...

Continue reading

EnBW International Finance B.V. : Annual report

In accordance with the Transparency Directive (Directive 2004/109/EC), as amended by the Transparency Directive Amending Directive (Directive 2013/50/EU), and following the choice of EnBW International Finance B.V. for The Netherlands as Home Member State, EnBW International Finance B.V. hereby informs that the financial reports at year end 31 December 2023 have been filed on 18 March 2024 with the Autoriteit Financiële Markten (AFM) in the Netherlands and are available on   https://www.enbw.com/media/downloadcenter/annual-financial-statement-of-enbw-international-finance-b-v/financial-report-2023-enbw-international-finance-b-v.pdf

Continue reading

The Real Good Food Company to Participate in the 36th Annual ROTH Conference

CHERRY HILL, N.J., March 18, 2024 (GLOBE NEWSWIRE) — The Real Good Food Company, Inc. (NASDAQ: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen and refrigerated foods company, today announced that management will participate in the 36th Annual ROTH Investor Conference taking place March 18-19, 2024 in Dana Point, California. Members of the management team are scheduled to host one-on-one and group meetings with institutional investors and analysts at the conference as follows. 36th Annual ROTH Investor Conference Date: Tuesday, March 19, 2024Location: The Ritz-Carlton – Dana Point, California Registration is required for conference participation. For more information or to schedule a meeting, please contact your ROTH representative or contact the RGF investor relations team directly at RGF@mzgroup.us. About...

Continue reading

Genius Group and OpenExO Sign Merger Agreement, Accelerating Plans to Build Global AI Education Group

SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, and OpenExO (“OpenExO”) an AI-driven global community of 36,000 educators, entrepreneurs and enterprises building the exponential ecosystems of the future, today signed a definitive agreement to merge companies in an all-share transaction. This merger accelerates our plan to build a worldwide AI Education Group serving a global network of 100 Genius Cities and prepare 100 million students for our exponential future. Salim Ismail founded OpenExO with Kent Langley. They have built a reputation as a world leading expert in exponential thinking. Salim is the author of the international bestseller “Exponential Organizations” and “Exponential Organizations 2.0, The...

Continue reading

Kering: Monthly statement on the total number of shares and voting rights (March 2024)

KeringSociété anonyme with a share capital of €493,683,112Head office: 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARIS   March 18, 2024 Monthly statementon the total number of shares and voting rights(articles L.233-8 of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers)Date     Total number ofshares   Total number of voting rightstheoretical 1 exercisable 2March 15, 2024 123,420,778 176,635,001 175,800,1541 Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulation). 2 Excluding treasury shares stripped of voting rights.  AttachmentKering – Statement Number of Shares and voting rights – 15.03.2024 ...

Continue reading

Transgene Announces Upcoming Investor Meetings

Strasbourg, March 18, 2024 – 05:45 pm CET TRANSGENE (Paris: TNG) today announces that Management will participate in several investor events in the upcoming months, as set out below.Investor Access Event (Paris, France): April 5, 2024, Van Lanschot Kempen Life Sciences Conference (Amsterdam, Netherlands): April 16, 2024, Oddo BHF Nextcap Forum (virtual): June 6, 2024.ContactsTransgene:Lucie Larguier +33 (0)3 88 27 91 04investorrelations@transgene.fr Media: MEDiSTRAVA ConsultingFrazer Hall/Sylvie Berrebi+44 (0)203 928 6900transgene@medistrava.comAbout Transgene Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells. The Company’s...

Continue reading

KPN reports on progress of € 200m share buyback

KPN has repurchased 3,355,000 KPN ordinary shares in the period from 11 March to 15 March 2024. The shares were repurchased at an average price of € 3.42 per share for a total consideration of € 11.5m. These repurchases were made as part of the € 200m share buyback started on 1 February 2024, and are part of KPN’s commitment to structurally return additional capital to its shareholders. The total number of ordinary shares repurchased to date is 37,981,404 for a total consideration of € 125.0m. Transaction details of the share buyback are available on our website. For more information:KPN Royal Dutch TelecomInvestor RelationsWilhelminakade 1233072 AP RotterdamE-mail: ir@kpn.com Formal disclosures: Royal KPN N.V. Head of IR: Reinout van Ierschot Inside information: Yes Topic: KPN reports on progress of € 200m share buyback18/03/2024;...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.